Bart L Haagmans Selected Research

Coronavirus M Proteins

8/2003

The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bart L Haagmans Research Topics

Disease

48	Infections 12/2022 - 01/2002
22	COVID-19 12/2022 - 01/2020
10	Virus Diseases (Viral Diseases) 01/2022 - 11/2003
9	Chronic Hepatitis C 01/2014 - 06/2003
5	Coronavirus Infections 05/2020 - 10/2014
4	Chronic Hepatitis B 01/2014 - 09/2006
2	Pneumonia (Pneumonitis) 12/2022 - 01/2021
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 06/2017
2	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2020
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 05/2020 - 10/2009
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 08/2007
2	Hepatitis 11/2014 - 08/2003
1	Disease Progression 12/2022
1	Zoonoses 06/2022
1	Critical Illness (Critically Ill) 01/2022
1	Hyperplasia 01/2022
1	Asymptomatic Infections 12/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Cytokine Release Syndrome 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Acute Disease 01/2018
1	Viremia 05/2016
1	Multiple Sclerosis 02/2016
1	Reinfection 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 08/2013
1	Animal Disease Models 01/2013
1	Obesity 01/2012
1	West Nile Fever 04/2011
1	Inflammation (Inflammations) 02/2010

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 06/2022 - 04/2011
13	Neutralizing AntibodiesIBA 02/2022 - 03/2006
13	AntibodiesIBA 01/2022 - 03/2013
12	Antiviral Agents (Antivirals)IBA 07/2022 - 11/2003
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
10	InterferonsIBA 01/2014 - 06/2003
8	Monoclonal AntibodiesIBA 01/2022 - 06/2004
7	Ribavirin (Virazole)FDA LinkGeneric 01/2013 - 06/2003
5	RNA (Ribonucleic Acid)IBA 01/2019 - 02/2011
4	Viral RNAIBA 11/2021 - 08/2013
3	Biological ProductsIBA 01/2022 - 10/2009
3	LipopeptidesIBA 01/2022 - 11/2020
3	Pharmaceutical PreparationsIBA 01/2021 - 03/2004
3	AntigensIBA 01/2021 - 03/2004
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2018 - 08/2013
3	Interferon-alpha (Interferon Alfa)IBA 01/2007 - 06/2003
2	Viral AntigensIBA 01/2022 - 03/2019
2	Immunoglobulin G (IgG)IBA 11/2021 - 04/2004
2	Viral ProteinsIBA 01/2021 - 08/2013
2	Staphylococcal Protein A (Protein A)IBA 05/2020 - 10/2014
2	CytokinesIBA 01/2013 - 08/2007
2	ChemokinesIBA 01/2013 - 08/2007
2	Hepatitis B e AntigensIBA 01/2007 - 09/2006
1	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022
1	molnupiravirIBA 07/2022
1	remdesivirIBA 07/2022
1	Complement System Proteins (Complement)IBA 02/2022
1	Immune Sera (Antisera)IBA 01/2022
1	BNT162 VaccineIBA 01/2021
1	NanovaccinesIBA 01/2021
1	Subunit VaccinesIBA 05/2020
1	Protein Subunit VaccinesIBA 05/2020
1	Inactivated VaccinesIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Broadly Neutralizing AntibodiesIBA 01/2020
1	EpitopesIBA 01/2020
1	Neuraminidase (Sialidase)IBA 01/2019
1	LigandsIBA 01/2019
1	Cell Surface ReceptorsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	GoldIBA 01/2018
1	Edetic Acid (EDTA)FDA Link 05/2016
1	AutoantigensIBA 02/2016
1	Ouabain (G Strophanthin)IBA 04/2015
1	Cardiac GlycosidesIBA 04/2015
1	bufalinIBA 04/2015
1	src-Family KinasesIBA 04/2015
1	Adenosine Triphosphatases (ATPase)IBA 04/2015
1	Small Interfering RNA (siRNA)IBA 11/2014
1	Adenosine DeaminaseIBA 02/2014
1	Carrier Proteins (Binding Protein)IBA 02/2014
1	AerosolsIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	NF-kappa B (NF-kB)IBA 02/2010
1	Interferon Type IIBA 02/2010
1	B 956IBA 07/2008
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 07/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008
1	IntegrinsIBA 07/2008
1	InterleukinsIBA 08/2007
1	Interleukin-8 (Interleukin 8)IBA 08/2007
1	Interferon-alpha2bIBA 01/2007
1	Interleukin-4 (Interleukin 4)IBA 09/2006

Therapy/Procedure

12	Therapeutics 02/2022 - 06/2003
2	Intranasal Administration 01/2021 - 11/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Hand Hygiene 01/2017
1	Length of Stay 01/2017
1	Liver Transplantation 11/2006